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Abstract 
Background: Cumulating evidence has shown a close correlation between electroacupuncture stimulation (EAS) 
frequency-specific analgesic effect and central opioid peptides. However, the actions of hippocampal acetylcholiner-
gic receptors have not been determined. This study aims to observe the effect of different frequencies of EAS on the 
expression of hippocampal muscarinic and nicotinic acetylcholinergic receptors (mAChRs, nAChRs) in neuropathic 
pain rats for revealing their relationship.
Methods: Forty male Wistar rats were randomly and equally divided into sham, CCI model, 2, 2/15 and 100 HzEA 
groups. The neuropathic pain model was established by ligature of the left sciatic nerve to induce chronic constric-
tion injury (CCI). EAS was applied to bilateral Zusanli (ST36) and Yanglingquan (GB34) for 30 min, once daily for 14 days 
except weekends. The mechanical pain thresholds (withdrawal latencies, PWLs) of bilateral hindpaws were measured. 
The expression levels of hippocampal M1 and M2 mAChR, and α4 and β2 nAChR genes and proteins were detected 
by quantitative RT-PCR and Western blot, separately. The involvement of mAChR and nAChR in the analgesic effect 
of EAS was confirmed by intra-hippocampal microinjection of M1mAChR antagonist (Pirenzepine) and α4β2 nAChR 
antagonist (dihydro-beta-erythroidine) respectively.
Results: Following EAS, the CCI-induced increase of difference values of bilateral PWLs on day 6 and 14 was signifi-
cantly reduced (P < 0.05), with 2/15 Hz being greater than 100 Hz EAS on day 14 (P < 0.05). After 2 weeks’ EAS, the 
decreased expression levels of M1 mAChR mRNA of both 2 and 2/15 Hz groups and M1 mAChR protein of the three 
EAS groups, α4 AChR mRNA of the 2/15 Hz group and β2 nAChR protein of the three EAS groups were considerably 
increased (P < 0.05), suggesting an involvement of M1 mAChR and β2 nAChR proteins in EAS-induced pain relief. No 
significant changes were found in the expression of M2 mAChR mRNA and protein, α4 nAChR protein and β2 nAChR 
mRNA after CCI and EAS (P > 0.05). The analgesic effect of EAS was abolished by intra-hippocampal microinjection of 
M1mAChR and α4β2 nAChR antagonists respectively.
Conclusions: EAS of ST36-GB34 produces a cumulative analgesic effect in neuropathic pain rats, which is frequency-
dependent and probably mediated by hippocampal M1 mAChR and β2 nAChR proteins.
Keywords: Neuropathic pain, Electroacupuncture analgesia, Stimulating frequencies, Hippocampus, M1 muscarinic 
acetylcholinergic receptor (M1 mAChR), M2 mAChR, Alpha-4 nicotinic AChR (nAChR), Beta-2 nAChR
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Background
It has been well documented that chronic pain includ-
ing neuropathic pain involves complex brain circuits for 
sensory, emotional, cognitive and interoceptive process-
ing [1, 2]. The hippocampus, one of the limbic structures 
for antinociception [3], has been shown to undergo sig-
nificant changes including reduction of hippocampal 
volume, learning and emotional deficits, sustained endo-
crine stress response, etc., in chronic pain syndrome 
patients [4–8], and abnormal expression of cytokine, 
extracellular signal-regulated kinase, neurokinin-1 (NK-
1) receptor, etc., in experimental chronic neuropathic 
pain animals [9–11].
Among the neurotransmitters or mediators involving 
the chronic pain induced abnormal behavioral deficits, 
acetylcholine (ACh) is an important candidate in the hip-
pocampus. Studies repeatedly demonstrated that cholin-
ergic compounds produced antinociceptive effects in the 
rhesus monkey [12], cat [13] and rat [14–17]. Systemic 
administration of cholinesterase inhibitors which cross 
the blood brain barrier was found to produce analgesia 
and enhance analgesia from opiates [18, 19].
Early studies on acupuncture analgesia have already 
shown that hippocampal cholinergic activities are 
involved in acupuncture analgesia [20–22]. But, related 
researches are relatively fewer. In recent years, we dem-
onstrated that both hippocampal and hypothalamic 
cholinergic activities were involved in the cumulative 
analgesia induced by repeated electroacupuncture stim-
ulation (EAS) of “Zusanli” (ST36) and “Yanglingquan” 
(GB34) in rats with chronic constrictive injury (CCI) of 
the sciatic nerve [23, 24]. However, the detailed mecha-
nisms underlying involvement of ACh in analgesia are 
still not clear.
Moreover, stimulating parameters, particularly the fre-
quency, are important factors affecting the analgesic effect 
of EAS [25]. Chen and Wang [26] reported that in 252 
cases of soft tissue injury-induced pain patients, 100  Hz 
EAS was significantly better than 2  Hz EAS in the cure 
rate and effective rate for pain. On the contrary, Zou et al. 
[27] observed that in 90 cases of acute arthritis patients, 
2 Hz EAS was apparently better than 100 Hz EAS in pain-
relief. Experimental studies also showed contradictory 
results about the analgesic effect of different frequencies 
of EAS in different acute pain models [28, 29].
In regard to the analgesic mechanisms of different 
EAS frequencies, majority of researches focused on the 
release of endogenous opioid peptides, one of which is 
Han’s and his colleagues’ well-known conclusion that 
2  Hz EAS induced analgesia mediated by the release of 
met-enkephalin (M-ENK) and β-endorphin (β-EP), while 
100  Hz EAS via dynorphin-A (DYN-A) in the central 
nervous system [30–34]. Latter, 5-HT in the brainstem 
[35, 36], catecholamine [37, 38], hypothalamic substance 
P [39], cholecystokinin (CCK) and CCK-A and -B recep-
tors [40] were found to be involved in the frequency-spe-
cific analgesic effect. However, to our knowledge, there 
have been no any reports on the cholinergic involve-
ment of frequency-specific analgesic effect of EAS. For 
this reason, the present study was designed to observe 
the effect of EAS at different frequencies on pain behav-
iors and expressions of hippocampal muscarinic acetyl-
choline receptor (mAChR) and nicotinic acetylcholine 
receptor (nAChR) in CCI-induced neuropathic pain rats, 
thereby, to better our understanding on the mechanism 
of acupuncture in the management of neuropathic pain.
Methods
Animals and grouping
Male Wistar rats (230–270  g) were obtained from the 
Experimental Animal Center of Peking Union Medical 
College (Beijing, China), and housed within the animal 
care facilities in the Institute of Acupuncture and Moxi-
bustion, China Academy of Chinese Medical Sciences. 
Rats were housed in a climate-controlled room on a 12 h 
light/dark cycle with food and water provided  ad libi-
tum. Animals were randomly divided into control (sham 
ligature), CCI model, CCI + 2 HzEA, CCI + 2/15 HzEA 
and CCI  +  100  HzEA groups (n  =  8 in each group). 
For verifying the effect of hippocampal mAChRs and 
nAChRs on EA analgesia, additional 30 male Wistar rats 
were randomized into control, model, saline-injection 
(saline), M1R-antagonist and nAChR-antagonist groups 
(n = 4 in each group). All experimental procedures were 
approved by the Institute of Acupuncture and Moxibus-
tion of China Academy of Chinese Medical Sciences, and 
performed according to the “Guidelines for Laboratory 
Animal Care and Use” of the Chinese Ministry of Science 
and Technology (2006).
Neuropathic pain model and pain threshold detection
Following a 7-day environmental adaptation, rats were 
anesthetized (25  % urethane plus 1.5  % chloralose, 
0.4 mL/100 g body weight) and received CCI of the sci-
atic nerve as previously described [41]. Briefly, the left 
posterolateral thigh was routinely sterilized, and a 2 cm 
incision was made through the skin. The left common 
sciatic nerve was exposed at mid-thigh by blunt dissec-
tion through the biceps femoris. Four constrictive liga-
tures (4–0 silk sutures) were tied around the nerve at the 
distal end close to the bifurcation site (about 1 mm space 
between every two ligatures). The ligature was alright 
until a moderate muscular contraction of the leg was 
seen. The same procedure was performed for rats in the 
control group but without nerve ligature. The incision 
was then closed using 5–0 silk sutures.
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The paw withdrawal latency (PWL) (i.e., the mechani-
cal pain threshold) of the bilateral hind paws was 
detected using a Dynamic Plantar Aesthesiometer (Ugo 
Basile, 37450, Italy) before CCI, 3 days after CCI, and 1, 
6 and 14  days after EA treatment. Rats were placed on 
a metal mesh table and in an individual plexiglass hous-
ing at the same time. The steel rod (0.5 mm diameter) of 
37450 was pushed up to the plantar surface of the hind 
paw with increasing force (2.5  g/s). The cutoff pres-
sure was set to be 30 g and the threshold was recorded 
when the rat retracted its foot abruptly responding to the 
increased pressure. Thermal pain threshold was detected 
using PLANTAR TEST (Ugo Basile, 37370, Italy). The 
radiant heat source was focused on the plantar surface 
of the hindpaw, and light intensity was preset to obtain 
a baseline latency of approximately 15 s. Each rat under-
went three trials with a 5-min inter-trial interval, and 
the mean value of these trials was used as the PWL. To 
minimize differences in individual animals, the differ-
ence value of PWL (PWLD) between the healthy and 
the affected hindpaws was calculated. Their hypersen-
sitivities were defined as the presence of at least a 20 % 
decrease in pain threshold compared with pre-CCI base-
lines. Rats not exhibiting pain hypersensitivity after CCI 
were discarded.
Electroacupuncture intervention
Bilateral Zusanli (ST 36, 5 mm beneath the capitulum fib-
ulae and lateral posterior to the knee-joint) and Yangling-
quan (GB 34, about 5 mm superior-lateral to ST 36) were 
punctured with filiform needles (Gauge 28), respectively, 
and electrically stimulated using a HANS EA Apparatus 
(LH202, Beijing Huawei Industrial Developing Com-
pany, Beijing, China). EA (2 Hz, alternative 2/15, 100 Hz, 
1 mA) was administered for 30 min, once per day for 1 or 
2  weeks beginning from day 4 after surgery. For rats of 
hippocampal injection of M1mAChR and α4β2 nAChR 
antagonists, EA (2/15  Hz, 1  mA) was administered for 
30 min, once daily for 5 days before the injection.
Intra‑hippocampal injection
Under anesthesia with chloral hydrate (400 mg/kg i.p),the 
rat who experienced 3–5 days recovery from CCI opera-
tion was fixed in a stereotaxic instrument (Stoelting 
Co, USA) and stainless steel 26-gauge cannulae were 
implanted into the bilateral dorsal hippocampus (anter-
oposterior, −3.6 mm; medial-lateral, ± 3.1 mm; dorsoven-
tral, −2.4  mm) according to Paxinos’ and Watson’s Atlas 
[The Rat Brain in Stereotaxic Coordinates, 6th edition 
from George Paxinos, Charles Watson], and fixed with 
dental cement. The stainless steel obdurator was remained 
in the cannulae before injection for preventing obstruc-
tion. After implantation of the cannula, each rat was 
allowed to have a recovery period of at least 7 days before 
the experiments. For hippocampal injection, a mini-size 
pump (KDS310 Plus, kdScientific, USA) connected to the 
catheter was used for continuous infusion of antagonists 
[pirenzepine hydrochloride, M1mAChR selective antago-
nist, Sigma; dihydro-beta-erythroidine, an α4 β2 nAChR 
antagonist; Tocris, UK; dissolved in sterile saline to a con-
centration of 10  nmol/μL] or normal saline at a rate of 
1 μL/h/hemisphere. The injector was remained connected 
for an additional 1  min to allow the drug diffusion away 
from the tip of the cannula. Before and 3−5 days after CCI 
surgery, 1, 3, and 5 days after hippocampal injections and 
EAS (2/15 Hz, 1 mA duration of 30 min), the thermal and 
mechanical pain thresholds were detected respectively. 
Rats with cannula-desquamation or death were excluded 
in the present study. The location of the intra-hippocam-
pal catheter was confirmed by pantamine sky blue (0.2 %, 
1 μL) microinjection after completion of the experiments.
Quantitative RT‑PCR analysis
At the end of EA treatments, 6 randomly-selected rats 
of each group were deeply anesthetized with the anes-
thetics mentioned above, and the right hippocampus 
tissue was separated. Total RNA was extracted from 
the tissue using Trizol reagent (Invitrogen, USA). First-
strand cDNA was synthesized by a reverse transcriptase 
kit (Invitrogen, USA) according to the manufacturer’s 
instructions, and used as the template for quantita-
tive RT-PCR analysis on a ABI 7500 fast real time sys-
tem (Applied Biosystems, CA, USA), with β-actin as an 
internal control. Each reaction included 2  μl (25  ng/μl) 
of cDNA and was performed in triplicate.The primer 
sequences were as follows.
β-actin (NM_031144.3): 5′-GGAGATTACTGCCCTGG 
CTCCTA-3′ (Forward), 5′-GACTCATCGTACTCCTGC 
TTGCTG-3′ (Reverse) (bp:150); M1 mAChR (NM_ 
080773.1): 5′-GCTGGAAGGAAGAAGAAGAGGAG 
GA-3′ (Forward), 5′-GCTGGAAGGAAGAAGAAGAGG 
AGGA (Reverse) (bp:160); M2 mAChR (NM_031061): 
5′-CCATTCTCTTCTGGCAGTTCATCGT-3′ (Forward), 
TCTTTATTCTACTCTTGCTTGCCCG (Reverse) (bp: 
183); β2 nAChR (NM_019297.1): 5′-CGGGAAGCA 
GTGGATGGCGTA -3′ (Forward), 5′-GTCCTCCCTCA 
CACTCTGGTCATCA-3′ (Reverse) (bp: 78); α4 nAChR 
(NM_024354.1): 5′-ATGGATGAAACCTACCTGATGA 
GCA-3′ (Forward), 5′-GCTGGGGGTTGTAGCAGGC 
AC-3′ (Reverse) (bp: 130). Cycling conditions were as fol-
lows: denaturation (95  °C for 10 min), amplification and 
quantitation (95  °C for 15  s, 60  °C for 60  s) repeated 40 
times, and 72 °C for 32 s, with a single fluorescence meas-
urement at the end of 72  °C for 32  s segment) repeated 
35 times, a melting curve program (60–95  °C with a 
heating rate of 0.1  °C/s and continuous fluorescence 
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measurement) and a cooling step to 40  °C. Quantitative 
RT-PCR data were normalized with β-actin mRNA levels. 
Relative mRNA levels were expressed as 2-∆∆Ct values.
Western blot analysis
Fresh contralateral hippocampal tissues were initially 
homogenized in lysis buffer containing a cocktail of phos-
phatase and proteinase inhibitors (Roche). Tissue protein 
concentrations were determined using the BCA protein 
assay kit (Pierce, Rockford). Protein samples(total 40 μg, 
20 μl) were electrophoretically separated on a SDS-PAGE 
gel and transferred to polyvinylidene difluoride mem-
branes (0.45  um pores; Millipore, Bedford, MA). The 
membranes were blocked with 2  % bovine serum albu-
min (BSA, Amresco, USA) solution for 2 h at room tem-
perature (RT) and then incubated overnight at 4 °C with 
rabbit anti-M1 mAChR (1:2000, SC-9106, Santa) and 
mouse anti-M2 mAChR (1:2000, ab2805, Abcam), rabbit-
anti- α-4nAChR (1:5000, Abcam, ab124832), rat anti-β2 
nAChR (1:4000, ab24698, Abcam) primary antibodies. 
All antibodies were diluted in Tris-buffered saline solu-
tion containing 0.5 % Tween 20 (TBST) and 3.0 % BSA-
TBSA. After washing in TBST, the blots were incubated 
with horseradish peroxidase (HRP)-conjugated second-
ary antibody for 2  h at RT (1:20,000; goat anti-rabbit 
immunoglobulin G; and 1:10,000: goat anti-mice IgG, 
1:5000: goat anti-rat IgG). Following the rinse in TBST, 
the blots were developed using enhanced chemillumi-
nescence for 1  min and exposed onto chemilumines-
cent films. For densitomentric analyses, the blots were 
scanned and quantified using TotalLab Quant analysis 
software (Totallab Limited, England), and the result was 
expressed as the ratio of target gene immunoreactivity to 
GAPDH immunoreactivity.
Statistical analysis
Data were expressed as mean  ±  standard deviation 
(mean ± SD). Data were analyzed via one-way ANOVA 
(for mRNA and protein expression) or two-way ANOVA 
(for pain thresholds) when appropriate, followed by least 
significant difference (LSD) tests for comparing data 
between groups. A value of P < 0.05 was considered sta-
tistically significant.
Results
Effect of EAS on pain threshold
As showed in Fig. 1 that after ligature of the sciatic nerve 
to induce CCI, the PWLDs were significantly increased 
in rats of the model group (P < 0.05, Fig. 1), suggesting a 
mechanical hypersensitivity 3 days after surgery. In com-
parison with the CCI model group, the PWLDs were pro-
nouncedly decreased in rats of the CCI + EA2 Hz group 
and CCI + EA2/15 Hz group on day 6 and day 14 after 
CCI-operation (P  <  0.05), and 2  Hz and 2/15  Hz EAS 
were notably superior to that of 100  Hz EAS in reduc-
ing PWLDS (P < 0.05, Fig. 1). In addition, the analgesic 
effect was gradually increased along with the extension of 
EA intervention, suggesting an accumulative effect of EA 
treatments.
Effect of EAS on hippocampal M1 and M2 mAChR gene 
and protein expression
M1 mAChR
In comparison with the control group, the expres-
sion levels of both M1 mAChR mRNA and protein in 
the hippocampus were significantly down-regulated 
(P  <  0.05, Fig.  2a), suggesting an involvement of M1 
mAChR in the nociceptive reactions following CCI. 
When compared with the CCI group, the expression 
Fig. 1 Effect of different frequencies of electroacupuncture stimulation (EAS) of Zusanli (ST36) and Yanglingquan (GB34) on difference values of 
the bilateral hindpaw withdrawal latencies (PWLDs, mechanical pain threshold) in neuropathic pain rats (mean ± SD, g, n = 8 in each group); NOR 
normal group, Model group: CCI (chronic compressive injury), CCI + 2 Hz EAS group: 2 Hz EA, CCI + 2/15 Hz EAS group: 2/15 Hz EA, CCI + 100 Hz 
EAS group: 100 Hz EA (the same in Figs. 2, 3); *P < 0.05, vs the normal group; #P < 0.05, vs the model group; ∆P < 0.05, vs the 100 Hz EAS group
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levels of M1 mAChR mRNA in both CCI  +  EA2  Hz 
and CCI + EA2/15 Hz groups and protein expression in 
CCI + EA2 Hz, CCI + EA2/15 Hz and CCI + EA100 Hz 
groups were considerably upregulated following 
2  weeks’ treatment (P  <  0.05, Fig.  2b). The expression 
levels of M1 mAChR mRNA in both CCI  +  EA2  Hz 
group and CCI  +  EA2/15  Hz group were remark-
ably higher than that in the CCI  +  EA100  Hz group 
(P < 0.05, Fig. 2a). No significant differences were found 
among the three EAS groups in M1 mAChR protein 
expression levels, and between the CCI +  EA2  Hz and 
CCI +  EA2/15  Hz groups and between the CCI group 
and CCI  +  EA100  Hz groups in M1 mAChR mRNA 
expression levels (P > 0.05).
M2 mAChR
Compared to the control group, there were no appar-
ent changes in the expression levels of both M2 mAChR 
mRNA and protein in the hippocampus after CCI 
surgery (P > 0.05, Fig. 2c, d). In comparison to the CCI 
group, no obvious changes were found in the expression 
levels of both M2 mAChR mRNA and protein after EAS 
(P > 0.05, Fig. 2c, d).
Effect of EAS on hippocampal α4 and β2 nAChR gene 
and protein expression
α4 nAChR
Quantitative real-time PCR detection of both α4 
nAChR and β2 nAChR mRNA showed that only α4 
nAChR mRNA expression in the hippocampus was 
significantly down-regulated after CCI in the CCI 
group (P  <  0.05, Fig.  3a), while β2 nAChR mRNA 
expression had no marked changes in the CCI and the 
three EAS groups (P  >  0.05, Fig.  3c). Following EAS, 
α4 nAChR mRNA expression level was obviously up-
regulated in the CCI  +  EA2/15  Hz group (P  <  0.05, 
Fig.  3a), not in the CCI  +  2  Hz and CCI  +  100  Hz 
groups (P > 0.05).
Fig. 2 Effect of different frequencies of EAS of ST36-GB34 on expression of M1 and M2 AChR mRNA and proteins in the hippocampus in neuro-
pathic pain rats (mean ± SD, n = 6 in each group); a M1 AChR mRNA, b M1 AChR protein; c M2 AChR mRNA, d M2 AChR protein; *P < 0.05, vs the 
normal group; #P < 0.05, vs the model group; ^P < 0.05, vs the 2 Hz EAS group; •P < 0.05, vs the 2/15 Hz EAS group
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β2 nAChR
Western blot detection displayed that hippocampal α4 
nAChRprotein expression had no apparent changes 
after CCI in the CCI and the three EAS groups (P > 0.05, 
Fig.  3b), while β2 nAChR protein expression was sig-
nificantly down-regulated in the CCI group (P  <  0.05, 
Fig.  3d). After EAS, β2 nAChR protein expression 
levels of the CCI  +  EA2  Hz, CCI  +  EA2/15  Hz and 
CCI + EA100 Hz groups were considerably upregulated 
(P < 0.05, Fig. 3d). No significant differences were found 
among the three EAS groups in the expression of β2 
nAChR protein (P > 0.05).
Effect of hippocampal injection of M1mAChR and α4β2 
nAChR antagonist on EA analgesia
Results of Fig.  4 showed that the PWLDs of the 
model group at time-points of 6  h, 1, 3 and 5  days 
after CCI were significantly increased in the model 
group (P  <  0.001). Compared to the model group, the 
PWLD was significantly decreased in the EA  +  saline 
group (P  <  0.05) but not in the EA  +  Pirenzepine and 
EA + DHβE groups on day 5 after EAS (P > 0.05), sug-
gesting a reduction of EA analgesia after intra-hippocam-
pal injection of M1mAChR and α4β2 nAChR antagonists.
Discussion
Findings of the present study revealed that after one 
and two weeks’ EAS at 2 Hz and alternative frequencies 
of 2/15 Hz but not 100 Hz, the mechanical pain thresh-
olds were significantly increased, and the effects of 2 and 
2/15 Hz were superior to that of 100 Hz EAS beginning 
on day 6 and significantly on day 14 after EAS, meaning 
a better analgesic effect of lower frequency EAS in neu-
ropathic pain rats. These results are basically identical to 
Zou’s and colleagues’ outcomes acquired in acute arthri-
tis patients [27], Romita’s and colleagues’ study [42] and 
Li’s [16], Mayor’s [43], and Wang’s [29] reviews about 
experimental studies, but different to Chen’s and Wang’s 
Fig. 3 Effect of different frequencies of EAS of ST36-GB34 on expression of α4 nAChR and β2 nAChR mRNA and proteins in the hippocampus in 
neuropathic pain rats (mean ± SD, n = 6 in each group); a α4 nAChR mRNA, b α4 nAChR protein; c β2 nAChR mRNA, d β2 nAChR protein; *P < 0.05, 
vs the normal group; #P < 0.05, vs the model group; •P < 0.05, vs the 2/15 Hz EAS group
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outcomes obtained in soft tissue injury patients which 
100 Hz EAS was better than 2 Hz in pain relief [26] and 
also different to Hahm’s [28] and Chang’s and colleagues’ 
[44] results in which a comparable pain relief of 2  Hz 
and 100  Hz EAS was observed in ankle sprain rats and 
inflammatory pain mice.
Results of real-time RT-PCR and WB of the present 
study showed that following 2  weeks’ EAS, both 2 and 
2/15  Hz could obviously reverse CCI-induced decrease 
of M1mAChR mRNA and protein expression, and so did 
100 Hz EAS in upregulating M1mAChR protein expres-
sion. The effects of 2/15 Hz EAS were notably better than 
those of 100 Hz EAS in upregulating M1 mAChR mRNA 
and α4 nAChR mRNA expression, displaying a closer 
correlation between the EA analgesia at 2/15 Hz and M1 
mAChR and β2 nAChR protein expression levels in CCI 
rats, rather than M2 mAChR protein expression. Follow-
ing intra-hippocampal microinjection of M1 mAChR 
antagonist Pirenzepine and α-4β-2nAChR antagonist 
DHβE, both the increased thermal pain and mechanical 
pain thresholds were suppressed, denoting an involve-
ment of hippocampal M1 mAChR and α-4β2 nAChR in 
mediating the cumulative analgesic effect of EAS.
It is well known that the gene expression contains both 
transcription and transduction, and changes of the tar-
get genes detected by PCR only reflects up- or down-
regulation of a molecule at the transcription level with 
no relevance to physiological functions, while the relative 
expression of proteins detected by WB is simply referred 
to protein transduction, and directly involves functional 
activities. Thus, it is understandable that the expres-
sion levels of genes and proteins of α4 nAChR and β2 
nAChR did not show a positive correlation. No selective 
antagonists for simple α4 nAChR and simple β2 nAChR 
were found, we were forced to observe the effect of α4β2 
nAChR antagonist on EA analgesia.
Studies using retrograde tracing and excitotoxin lesions 
[45], ChAT and/or AChE pharmacohistochemical regi-
men [46] and co-cultured slices of septum and hippocam-
pus (not single cultures of hippocampus) in combination 
with immunocytochemistry for choline acetyltransferase 
(AChT) [47] demonstrated that the hippocampal for-
mation is innervated primarily by cholinergic neurons 
located in the vertical limb of the diagonal band and in 
the medial septum. It also has been shown that the cho-
linergic, opioidergic and GABAergic systems of the 
Fig. 4 Effect of intra-hippocampal injection of M1mAChR selective antagonist (pirenzepine hydrochloride) and α4β2 nAChR antagonist 
(Dihydro-beta-erythroidine, DHβE) on pain threshold (a mechanic, g; b thermal, sec) in neuropathic pain rats (mean ± SD, n = 4 in each group); 
*P < 0.05, vs the normal group; #P < 0.05, vs the model group
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hippocampus were involved in the modulation of antino-
ciception, and the cholinergic transmission may activate 
the release of endorphins/enkephalin from interneurons 
of the dorsal hippocampus to inhibit GABAergic neu-
rons, resulting in antinociception [48].
The hippocampus expresses a broad range of mAChRs, 
with the M1 and M3 receptors being mainly expressed 
on principal neurons and M2 and M4 receptors on 
interneurons [49, 50]. However, only fewer studies 
have shown roles of different subunits of hippocampal 
mAChRs and nAChR in pain modulation. For instance, 
intra-CA3 microinjection of ACh or ACh agonist pilo-
carpine and mAChRs antagonist atropine showed that 
hippocampal mAChRs were complicated in the modula-
tion of the nociceptive response by modulating the elec-
trical activities of pain-excited or -inhibited neurons in 
the hippocampal CA1 and CA3 regions of normal rats 
experiencing electrical stimulation of the ischial nerve 
[16, 51]. The hippocampal M1 mAChR was shown to be 
involved in moderate pain reactions in repeated intra-
peritoneal injection-induced moderate pain in C57BL/6J 
mice [52].
The septo-hippocampal pathway was also thought to 
activate nAChRs, because intraperitoneal injection of 
nAChR antagonist chlorisondamine induced an antino-
ciceptive effect in acute thermal (hot box) and persistent 
chemical (formalin test) pain rats [53]. At least three dis-
tinct functional nAChRsubtypes (α7, α4 β2, α3 β4) could 
be detected in the hippocampal region [54], and most 
of the rat hippocampal heteromeric nAChRs contain α4 
and β2 subunits, with the 3H] epibatidine –labeled α4β2 
and α4β2α5 subtypes accounting for about 40 and 35 %, 
respectively [55]. In accordance with Mitsui’s report [56], 
in spite of no obvious physical or neurological deficit in 
AChR knockout mice, pharmacological, biochemical, 
electrophysiological, neuroanatomical and behavioral 
analyses revealed that these AChR subunits may form 
a component of the nicotinic pain pathways modulat-
ing the antinociceptive effect of nicotine. Experimental 
results of tail-flick and hot-plate tests indicated that α4 
β2 nAChRs were important in mediating neuronal nico-
tinic analgesia in both spinal and supraspinal responses 
in knockin mice expressing hypersensitive α4 β2 nico-
tinic receptors [57]. However, there still have been no any 
reports on gene and protein expression of hippocampal 
nicotinic receptors involving pain modulation up to now.
EAS frequency is considered to be an important 
parameter affecting its analgesic effect. Up to now, many 
studies focus on the low frequency 2–5 Hz, medium fre-
quency 15–40  Hz, and high frequency 100–200  Hz for 
various pain models, which were chosen in considera-
tion of nervous tissue responses. If the frequency is over 
100 Hz, the reactions of the nerve tissue may not truth-
fully follow the electrical stimulation [25].
Using rat tail-flick tests, Silva et al. [58] observed that 
the analgesic effect of 2 Hz EAS of ST36 and Sanyinjiao 
(SP6) lasted longer than that of 100  Hz EAS. Intrathe-
cal administration of antagonists of α1- (WB4101) and 
α2- (idazoxan) adrenoceptors and serotonergic (meth-
ysergide), opioid (naloxone), muscarinic (atropine), 
GABA (A) (bicuculline) and GABA (B) (phaclofen) 
receptors showed that the analgesic effect of 2  HZ 
EAS was inhibited by naloxone or atropine, being less 
intense and shorter after α1 or α2 inhibition, and lasting 
shorter after 5-HT, GABAA, or GABAB receptor sup-
pression; while that of the 100 Hz EAS was less intense 
and shorter after opioid and muscarinic suppression, 
being less intense and longer after GABAB inhibition, 
shorter after 5-HT or GABAA inhibition, and remained 
unchanged after α1 or α2 inhibition. It suggests that the 
analgesic efficacy (intensity) of 2  Hz EAS depends on 
noradrenergic descending inhibition and involves spinal 
opioid and muscarinic mechanisms, whereas the dura-
tion of the analgesic effect relies on both noradrenergic 
and serotonergic descending control, and involves spinal 
GABAergic regulation. On the contrary, the analgesic 
efficacy of 100  Hz EAS involves spinal muscarinic, opi-
oid, and GABAB activation, while the duration of the 
effects is affected by spinal serotonergic, muscarinic, 
opioid, and GABAA activation. Their further study [59] 
demonstrated that the cholinergic muscarinic, μ-opioid, 
GABAA and 5-HT1 mechanisms in the dorsal -anterior 
pretectal nucleus (APtN) and μ-opioid and 5-HT1 mech-
anisms in the ventral APtN were involved in 2  Hz EAS 
analgesia, while the μ-opioid and 5-HT1 mechanisms in 
the vAPtN but not in the dAPtN were complicated in 
100 Hz EAS analgesia.
Recently, using cDNA microarray, Wang et  al. [60] 
demonstrated in the rat that more genes were differ-
entially regulated by 2  Hz EA than 100  Hz EA of ST36 
and SP6 (154 vs. 66 regulated genes/ESTs) in the arcu-
ate nucleus (Arc) region, especially those related to neu-
rogenesis. Results of fMRI in combination with behavior 
tests showed that following 2 and 100  Hz EAS in the 
human body, the regional cerebral blood flow (CBF) sig-
nals revealed a trend of early activation with later inhi-
bition; and a positive correlation between  analgesia  and 
the regional CBF change was observed in the anterior 
insula in the early stage, whereas a negative relationship 
was found in the parahippocampal gyrus in the later 
stage. TEAS analgesia was specifically associated with the 
default mode network and other cortical regions in the 
2  Hz TEAS group, ventral striatum and dorsal anterior 
cingulate cortex in the 100 Hz TEAS group, respectively 
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[61]. Later, it was found in rhesus monkeys that 2 Hz but 
not 100  Hz TEAS evoked a significant increase in mu-
opioid receptor (MOR) binding potential in the anterior 
cingulate cortex, caudate nucleus, putamen, temporal 
lobe, somatosensory cortex, and the amygdala which are 
related to pain and sensory processing [62]. These findings 
suggest that the mechanisms of low- and high-frequency 
EAS analgesia are different and partially overlapped.
Conclusions
Results of our present study showed that in neuropathic 
pain rats, repeated EA treatment at frequencies of 2 
and 2/15 Hz, particularly the later (but not 100 Hz) has 
a cumulative analgesic effect, which is closely related to 
their effects in upregulating the expression of hippocam-
pal M1 and β2 nAChR proteins, highlighting the involve-
ment of muscarinic and nicotinic receptor subtypes in 
EA analgesia for the first time.
Abbreviations
CCI: chronic constrictive injury; EAS: electroacupuncture stimulation; PWL: 
paw withdrawal latency; PWLD: difference value of PWL; M1 mAChR: M1 mus-
carinic acetylcholinergic receptor; M2 mAChR: M2 muscarinic acetylcholiner-
gic receptor,; α-4nAChR: alpha-4 nicotinic acetylcholinergic receptor; Beta-2 
nAChR: beta-2 nicotinic acetylcholinergic receptor.
Authors’ contributions
SPC and JLL wrote the manuscript. YK and SPC carried out the animal experi-
ments, JLZ, JYW and YHG participated in partial experiments and executed 
statistical analysis, and LNQ and XMF helped the experiments. JLL contributed 
to the design of the study. All authors read and approved the final manuscript.
Author details
1 Department of Physiology, Institute of Acupuncture and Moxibustion, China 
Academy of Chinese Medical Sciences, 16 Nanxiaojie Street, Dongzhimennei, 
Beijing 100700, China. 2 Department of Biochemistry and Molecular Biology, 
Institute of Acu-Moxibustion, China Academy of Chinese Medical Sciences, 
Beijing, China. 
Acknowledgements
This study was jointly supported by National Natural Science Foundation of 
China (No.81273828, No.81202762, and No.30973796) and the Special Project 
of Chinese Medicine (973) of the National Basic Research Program of China 
(2007CB512505, 2013CB531904).
Competing interests
All authors declare that they have no any competing interests.
Received: 6 November 2015   Accepted: 19 March 2016
References
 1. Simons LE, Elman I, Borsook D. Psychological processing in chronic pain: a 
neural systems approach. Neurosci Biobehav Rev. 2014;39:61–78.
 2. Farmer MA, Baliki MN, Apkarian AV. A dynamic network perspective of 
chronic pain. Neurosci Lett. 2012;520(2):197–203.
 3. Liu M-G, Chen J. Roles of the hippocampal formation in pain information 
processing. Neurosci Bull. 2009;25(5):237–66.
 4. Pruessner M, Pruessner JC, Hellhammer DH, Bruce Pike G, Lupien SJ. The 
associations among hippocampal volume, cortisol reactivity, and mem-
ory performance in healthy young men. Psychiatry Res. 2007;155(1):1–10.
 5. Zimmerman ME, Pan JW, Hetherington HP, Lipton ML, Baigi K, Lipton RB. 
Hippocampal correlates of pain in healthy elderly adults: a pilot study. 
Neurology. 2009;73:1567–70.
 6. Mutso AA, Petre B, Huang L, Baliki MN, Torbey S, Herrmann K, et al. 
Reorganization of hippocampal functional connectivity with transition to 
chronic back pain. J Neurophysiol. 2014;111(5):1065–76.
 7. Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, et al. 
Abnormalities in hippocampal functioning with persistent pain. J Neuro-
sci. 2012;32(17):5747–56.
 8. Vachon-Presseau E, Roy M, Martel MO, Caron E, Marin MF, Chen J, et al. The 
stress model of chronic pain: evidence from basal cortisol and hippocam-
pal structure and function in humans. Brain. 2013;136(Pt 3):815–27.
 9. Al-Amin H, Sarkis R, Atweh S, Jabbur S, Saade N. Chronic dizocilpine 
or apomorphine and development of neuropathy in two animal 
models II: effects on brain cytokines and neurotrophins. Exp Neurol. 
2011;228:30–40.
 10. del Rey A, Yau HJ, Randolf A, Centeno MV, Wildmann J, Martina M, et al. 
Chronic neuropathic pain-like behavior correlates with IL-1 expres-
sion and disrupts cytokine interactions in the hippocampus. Pain. 
2011;152:2827–35.
 11. Duric V, McCarson KE. Persistent pain produces stress-like altera-
tions in hippocampal neurogenesis and gene expression. J Pain. 
2006;7(8):544–55.
 12. Pert A. The cholinergic system and nociception in the primate: interac-
tions with morphine. Psychopharmacologia. 1975;44(2):131–7.
 13. Katayama Y, Watkins LR, Becker DP, Hayes RL. Non-opiate analgesia 
induced by carbachol microinjection into the pontine parabrachial 
region of the cat. Brain Res. 1984;296(2):263–83.
 14. Hamm RJ, Knisely JS. Developmental differences in the analge-
sia produced by the central cholinergic system. Dev Psychobiol. 
1987;20(3):345–54.
 15. Jiao R, Yang C, Zhang Y, Xu M, Yang X. Cholinergic mechanism involved 
in the nociceptive modulation of dentate gyrus. Biochem Biophys Res 
Commun. 2009;379(4):975–9.
 16. Li GZ, Liang QC, Jin YH, Yang CX, Zhang GW, Gao HR, et al. The effect of 
acetylcholine on pain-related electric activities in the hippocampal CA3 
of rats. J Neural Transm. 2011;118(4):555–61.
 17. Romano JA, Shih TM. Cholinergic mechanisms of analgesia produced by 
physostigmine, morphine and cold water swimming. Neuropharmacol-
ogy. 1983;22(7):827–33.
 18. Eisenach JC. Muscarinic-mediated analgesia. Life Sci. 
1999;64(6–7):549–54.
 19. Lewis JW, Cannon JT, Liebeskind JC. Involvement of central mus-
carinic cholinergic mechanisms in opioid stress analgesia. Brain Res. 
1983;270(2):289–93.
 20. Tang CM, Wei JH, Chen SS. Preliminary study on the involvement 
of hippocampus in electroacupuncture analgesia. Zhen Ci Ma Zui. 
1979;2(1):58–61.
 21. Xu G, Duanmu Z, Yin Q. The role of Ach in the central nerve system on 
pain modulation and analgesia. Zhen Ci Yan Jiu. 1993;18(1):1–5, 7.
 22. Guan XM, Wang CY, Yu F. Correlation between central acytcholine and 
acupuncture analgesia. Zhen Ci Yan Jiu. 1991;16(2):129–37.
 23. Wang JY, Liu JL, Chen SP, Gao YH, Meng FY, Qiao LN. Acupuncture effects 
on the hippocampal cholinergic system in a rat model of neuropathic 
pain. Neu Reg Res. 2012;7(3):212–8.
 24. Wang JY, Meng FY, Chen SP, Gao YH, Liu JL. Analysis on Interrelation 
between electroacupuncture-induced cumulative analgesic effect and 
hypothalamic cholinergic activities in chronic neuropathic pain rats. Chin 
J Integr Med. 2012;18(9):699–707.
 25. Han JS. Some factors affecting acupuncture-induced analgesia. Zhen Ci 
Yan Jiu. 1994;19(3, 4):1–4.
 26. Chen HL, Wang QQ. Effect of different frequency electrical stimulation of 
acupoints on pain of acute soft tissue injury. J Chengdu Univer Trad Chin 
Med. 2006;29(4):29–31.
 27. Zou R, Zhang HX, Zhang TF. Comparative study on treatment of acute 
gouty arthritis by electroacupuncture with different frequency. Chin J 
Clin Rehabil. 2006;10(43):188–9.
 28. Hahm TS. The effect of 2 Hz and 100 Hz electrical stimulation of acupoint 
on ankle sprain in rats. J Korean Med Sci. 2007;22(2):347–51.
 29. Wang YJ. An outline of experimental studies on the factors affecting 
electroacupuncture analgesia. Zhen Ci Yan Jiu. 1993;18(4):247–52.
Page 10 of 10Chen et al. Behav Brain Funct  (2016) 12:13 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 30. Han JS, Wang Q. Mobilization of specific neuropeptides by peripheral 
stimulation of identified frequencies. News Physiol Sci. 1992;7(4):176–80.
 31. Fei H, Sun SL, Han JS. New evidence supporting differential release of 
enkephalin and dynorphin by low and high frequency electro-acupunc-
ture. Chin Sci Bull. 1988;33(9):703–5.
 32. Fei H, Xie GX, Han JS. Low and high frequency electro-acupuncture 
stimulations release [met5] enkephalin and dynorphin A in rat spinal 
cord. Chin Sci Bull. 1987;32(21):1496–501.
 33. Wang Y, Zhang Y, Wang W, Cao Y, Han JS. Effects of synchronous or 
asynchronous electroacupuncturestimulation with low versus high 
frequency on spinal opioid release and tail flick nociception. Exp Neurol. 
2005;192(1):156–62.
 34. Wang Q, Mao L, Han J. The arcuate nucleus of hypothalamus mediates 
low but not highfrequencyelectroacupunctureanalgesia in rats. Brain Res. 
1990;513(1):60–6.
 35. Zhang M, Han JS. 5-hydroxytryptamine is an important mediator for both 
high and low frequency electroacupuncture analgesia. Zhen Ci Yan Jiu. 
1985;10(3):212–5.
 36. Kwon YB, Kang MS, Son SS, Kim JT, Lee YH, Han HJ, Lee JH. Different 
frequencies of electroacupuncture modified the cellular activity of sero-
tonergic neurons in brainstem. Am J Chin Med. 2000;28(3–4):435–41.
 37. Kwon Y, Kang M, Ahn C, Han H, Ahn B, Lee J. Effect of high or low fre-
quency electroacupuncture on the cellular activity of catecholaminergic 
neurons in the brain stem. Acupunct Electrother Res. 2000;25(1):27–36.
 38. Shen EY, Lai YJ. The efficacy of frequency-specific acupuncture stimula-
tion on extracellular dopamine concentration in striatum–a rat model 
study. Neurosci Lett. 2007;415(2):179–84.
 39. Lin YP, Peng Y, Yi SX, Tang S. Effect of different frequency electroacu-
puncture on the expression of substance P and beta-endorphin in the 
hypothalamus in rats with gastric distension-induced pain. Zhen Ci Yan 
Jiu. 2009;34(4):252–7.
 40. Ko ES, Kim SK, Kim JT, Lee G, Han JB, Rho SW, et al. The difference in 
mRNA expressions of hypothalamic CCK and CCK-A and -B receptors 
between responder and non-responder rats to high frequency electroa-
cupuncture analgesia. Peptides. 2006;27(7):1841–5.
 41. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces 
disorders of pain sensation like those seen in man. Pain. 1988;33:87–107.
 42. Romita VV, Suk A, Henry JL. Parametric studies on electroacupuncture-like 
stimulation in a rat model: effects of intensity, frequency, and duration of 
stimulation on evoked antinociception. Brain Res Bull. 1997;42(4):289–96.
 43. Mayor D. An exploratory review of the electroacupuncture literature: 
clinical applications and endorphin mechanisms. Acupunct Med. 
2013;31(4):409–15.
 44. Chang FC, Tsai HY, Yu MC, Yi PL, Lin JG. The central serotonergic system 
mediates the analgesic effect of electroacupuncture on ZUSANLI (ST36) 
acupoints. J Biomed Sci. 2004;11(2):179–85.
 45. McKinney M, Coyle JT, Hedreen JC. Topographic analysis of the innerva-
tion of the rat neocortex and hippocampus by the basal forebrain 
cholinergic system. J Comp Neurol. 1983;217(1):103–21.
 46. Woolf NJ, Eckenstein F, Butcher LL. Cholinergic systems in the rat brain: I. 
projections to the limbic telencephalon. Brain Res Bull. 1984;13(6):751–84.
 47. Heimrich B, Frotscher M. Formation of the septohippocampal projection 
in vitro: an electron microscopic immunocytochemical study of choliner-
gic synapses. Neuroscience. 1993;52(4):815–27.
 48. Favaroni Mendes LA. Menescal-de-Oliveira L. Role of cholinergic, 
opioidergic and GABA-ergic neuro-transmission of the dorsal hip-
pocampus in the modulation of nociception in guinea pigs. Life Sci. 
2008;83(19–20):644–50.
 49. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ. Expression of 
m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus 
and regulation by cholinergic innervation. J Neurosci. 1995;15:4077–92.
 50. Hajos N, Papp EC, Acsady L, Levey AI, Freund TF. Distinct interneuron 
types express m2 muscarinic receptor immunoreactivity on their 
dendrites or axon terminals in the hippocampus. Neuroscience. 
1998;82:355–76.
 51. Yang XF, Xiao Y, Xu MY. Both endogenous and exogenous ACh plays 
antinociceptive role in the hippocampus CA1 of rats. J Neural Transm. 
2008;115(1):1–6.
 52. Sase A, Khan D, Höger H, Lubec G. Intraperitoneal injection of saline mod-
ulates hippocampal brain receptor complex levels but does not impair 
performance in the Morris Water Maze. Amino Acids. 2012;43(2):783–92.
 53. Bannon AW, Decker MW, Curzon P, Buckley MJ, Kim DJ, Radek RJ, et al. 
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally 
effective antinociceptive agent acting via neuronal nicotinic acetyl-
choline receptors: II. In vivo characterization. J Pharmacol Exp Ther. 
1998;285(2):787–94.
 54. Alkondon M, Alkondon M, Albuquerque EX. The nicotinic acetylcholine 
receptor subtypes and their function in the hippocampus and cerebral 
cortex. Prog Brain Res. 2004;145:109–20.
 55. Lomazzo E, MacArthur L, Yasuda RP, Wolfe BB, Kellar KJ. Quantitative 
analysis of the heteromeric neuronal nicotinic receptors in the rat hip-
pocampus. J Neurochem. 2010;115:625–34.
 56. Mitsui T. Acetylcholine receptor knockout mice. Nihon Shinkei Seishin 
Yakurigaku Zasshi. 1999;19(5):233–8.
 57. Damaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, et al. 
Genetic approaches identify differential roles for α4β2 nicotinic recep-
tors in acute models of antinociception in mice. J Pharmacol Exp Ther. 
2007;321(3):1161–9.
 58. Silva JR, Silva ML, Prado WA. Analgesia induced by 2- or 100-Hz electroa-
cupuncture in the rat tail-flick test depends on the activation of different 
descending pain inhibitory mechanisms. J Pain. 2011;12(1):51–60.
 59. Silva ML, Silva JR, Prado WA. Analgesia induced by 2- or 100-Hz electroa-
cupuncture in the rat tail-flick test depends on the anterior pretectal 
nucleus. Life Sci. 2013;93(20):742–54.
 60. Wang K, Zhang R, He F, Lin LB, Xiang XH, Ping XJ, et al. Electroacupunc-
ture frequency-related transcriptional response in rat arcuate nucleus 
revealed region-distinctive changes in response to low- and high-fre-
quency electroacupuncture. J Neurosci Res. 2012;90(7):1464–73.
 61. Jiang Y, Liu J, Liu J, Han J, Wang X, Cui C. Cerebral blood flow-based 
evidence for mechanisms of low- versus high-frequency transcutaneous 
electric acupoint stimulation analgesia: a perfusion fMRI study in humans. 
Neuroscience. 2014;268C:180–93.
 62. Xiang XH, Chen YM, Zhang JM, Tian JH, Han JS, Cui CL. Low- and high-
frequency transcutaneous electrical acupoint stimulation induces differ-
ent effects on cerebral μ-opioid receptor availability in rhesus monkeys. J 
Neurosci Res. 2014;92(5):555–63.
